Carregant...
An update on antibody-based immunotherapies for Clostridium difficile infection
Clostridium difficile continues to be one of the most prevalent hospital-acquired bacterial infections in the developed world, despite the recent introduction of a novel and effective antibiotic agent (fidaxomicin). Alternative approaches under investigation to combat the anaerobic Gram-positive bac...
Guardat en:
| Publicat a: | Clin Exp Gastroenterol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4975149/ https://ncbi.nlm.nih.gov/pubmed/27536153 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEG.S84017 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|